Ronald Ghossein
Overview
Explore the profile of Ronald Ghossein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
130
Citations
4497
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Urken M, Urken M, Brandwein-Weber M, Chai R, Zafereo M, Shindo M, et al.
Eur Thyroid J
. 2025 Feb;
14(2).
PMID: 39946546
Objective: The final surgical pathology report follows the patient throughout their cancer journey. For locoregionally advanced cancers, lack of surgeon-pathologist communication can lead to understaging, adversely impacting management. Our study...
2.
Scholfield D, Xu B, Levyn H, Eagan A, Shaha A, Shah J, et al.
Thyroid
. 2025 Jan;
35(2):153-165.
PMID: 39761124
The 2022 World Health Organization classification introduced the term high-grade follicular cell-derived nonanaplastic thyroid carcinoma (HGFCTC) to define invasive/infiltrative nonanaplastic thyroid carcinoma with high-grade features, including poorly differentiated thyroid carcinoma...
3.
Xu B, Jungbluth A, Frosina D, Alabkaa A, Serrette R, Qin H, et al.
Head Neck Pathol
. 2024 Nov;
18(1):123.
PMID: 39589616
Purpose: BSND is a chloride channel subunit that is expressed in the normal salivary gland. We aimed to validate the utility of BSND immunohistochemistry in the differential diagnosis of oncocytic...
4.
Xu B, Baine M, Jungbluth A, Alabkaa A, Serrette R, Roy D, et al.
J Clin Endocrinol Metab
. 2024 Sep;
PMID: 39324657
Purpose: Seizure-related 6 homolog (SEZ6) is a cDNA that strongly associated with neuroendocrine differentiation. Recently, SEZ6 expression was found in a subset of small cell lung carcinoma (SCLC). Furthermore, ABBV-011,...
5.
Xu B, Roy D, Serrette R, Ghossein R
Histopathology
. 2024 Jul;
85(6):950-958.
PMID: 39030854
Aims: While CAP and ICCR protocols mandate the separation of angioinvasion (AI) and lymphatic invasion (LI) in thyroid carcinoma, distinction between them can be difficult. Because the presence of AI...
6.
Scholfield D, Fitzgerald C, Boe L, Eagan A, Levyn H, Xu B, et al.
Ann Surg Oncol
. 2024 Jun;
31(9):5525-5536.
PMID: 38847983
Background: Diffuse sclerosing papillary thyroid carcinoma (DSPTC) is an aggressive histopathologic subtype of papillary thyroid carcinoma. Correlation between genotype and phenotype has not been comprehensively described. This study aimed to...
7.
Viswanathan K, Hahn E, Dogan S, Weinreb I, Dickson B, MacMillan C, et al.
Histopathology
. 2024 May;
85(2):317-326.
PMID: 38708903
Background And Aim: Head and neck nuclear protein of testis carcinoma (HN-NUT) is a rare form of carcinoma diagnosed by NUT immunohistochemistry positivity and/or NUTM1 translocation. Although the prototype of...
8.
Ghossein R, Katabi N, Dogan S, Shaha A, Tuttle R, Fagin J, et al.
Histopathology
. 2024 Mar;
84(7):1130-1138.
PMID: 38528726
Aims: Papillary thyroid carcinoma, tall cell subtype (PTC-TC) is a potentially aggressive histotype. The latest World Health Organisation (WHO) classification introduced a novel class of tumours; namely, high-grade differentiated thyroid...
9.
Zanoni D, Demetrio de Souza Franca P, Valero C, Peterson G, Ardigo M, Ghossein R, et al.
Clin Cancer Res
. 2024 Mar;
30(11):2486-2496.
PMID: 38526414
Purpose: We investigated reflectance confocal microscopy (RCM) as a possible noninvasive approach for the diagnosis of cancer and real-time assessment of surgical margins. Experimental Design: In a phase I study...
10.
Scholfield D, Lopez J, Eagan A, Antal Z, Tuttle R, Ghossein R, et al.
J Clin Endocrinol Metab
. 2024 Feb;
109(8):e1684.
PMID: 38419483
No abstract available.